Introduction of UBT for PPH Management in Three Countries

NCT02910310 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60105

Last updated 2018-07-26

No results posted yet for this study

Summary

This study is a prospective, systematic evaluation to assess the effectiveness and safety of introduction of UBT into PPH care at secondary level and district hospitals in 3 low-resource countries. The first component of the evaluation is a prospective stepped wedge cluster randomized design to assess the potential reduction in PPH-related mortality and invasive procedures (blood transfusion, arterial ligation, hysterectomy and uterine arterial embolization) for PPH performed at participating facilities following introduction of UBT. The second component is a nested cohort analysis to assess the safety and acceptability of UBT among women diagnosed with PPH.

Conditions

  • Postpartum Hemorrhage

Interventions

OTHER

Uterine balloon tamponade

An intervention consisting of inserting a condom attached to a urinary catheter into the uterus and inflating it with fluid to stop postpartum bleeding

Sponsors & Collaborators

  • Ministry of Health and Population, Egypt

    collaborator OTHER_GOV
  • Alexandria University

    collaborator OTHER
  • El Galaa Teaching Hospital

    collaborator OTHER
  • Global Health Uganda LTD

    collaborator OTHER
  • Makerere University

    collaborator OTHER
  • Ministry of Health, Uganda

    collaborator OTHER_GOV
  • Ministere de la Sante et des Services Sociaux

    collaborator OTHER
  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Holly Anger, MPH · Gynuity Health Projects

  • Rasha Dabash, MPH · Gynuity Health Projects

  • Laura Frye, MPH · Gynuity Health Projects

  • Ayisha Diop, MPH · Gynuity Health Projects

  • Sam Ononge, MD · Makerere University

  • Nevine Hassanien, MD · Consultant

  • Mohamed Cherine Ramadan, MD · El Galaa Teaching Hospital

  • Emad Darwish, MD · Alexandria University

  • Bocar Daff, MD · Ministry of Health, Senegal

  • Beverly Winikoff, MD, MPH · Gynuity Health Projects

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-02-28
Completion
2018-03-31

Countries

  • Egypt
  • Senegal
  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02910310 on ClinicalTrials.gov